These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


341 related items for PubMed ID: 19188774

  • 1. Update on the medical management of stone disease.
    Tracy CR, Pearle MS.
    Curr Opin Urol; 2009 Mar; 19(2):200-4. PubMed ID: 19188774
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative value of orange juice versus lemonade in reducing stone-forming risk.
    Odvina CV.
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1269-74. PubMed ID: 17699358
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis.
    Seltzer MA, Low RK, McDonald M, Shami GS, Stoller ML.
    J Urol; 1996 Sep; 156(3):907-9. PubMed ID: 8709360
    [Abstract] [Full Text] [Related]

  • 9. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM, Preminger GM.
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG, Paquette EL, Cullen J, Gancarczyk KK, Tucciarone PR, Schenkman NS.
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [Abstract] [Full Text] [Related]

  • 12. Citrate, malate and alkali content in commonly consumed diet sodas: implications for nephrolithiasis treatment.
    Eisner BH, Asplin JR, Goldfarb DS, Ahmad A, Stoller ML.
    J Urol; 2010 Jun; 183(6):2419-23. PubMed ID: 20403610
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL, Nakada SY.
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dietary oxalate and calcium oxalate nephrolithiasis.
    Khan SR, Glenton PA, Byer KJ.
    J Urol; 2007 Nov; 178(5):2191-6. PubMed ID: 17870111
    [Abstract] [Full Text] [Related]

  • 18. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M, Capuano M, Cangiano G, Carnovale V, Ferrara P, Petrarulo M, Marangella M.
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [Abstract] [Full Text] [Related]

  • 19. The impact of societal changes on patterns of urolithiasis.
    Zilberman DE, Yong D, Albala DM.
    Curr Opin Urol; 2010 Mar; 20(2):148-53. PubMed ID: 19940772
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.